On Tuesday Nov. 5, 2019, Dr. Meinolf Brackhagen from DuPont Nutrition & Biosciences will discuss the current and future roles of excipient suppliers
On Tuesday Nov. 5, 2019, Dr. Meinolf Brackhagen, principal scientist, pharma solutions, DuPont Nutrition & Biosciences, will discuss the current and future roles of excipient suppliers at CPhI Worldwide in Frankfurt, Germany.
The Pharma Insights Briefings discussion, which is set to take place from 12:30 pm to 1:00 pm at stand 61D61in the CPhI Theatre, will touch upon the role excipients play in addressing quality and productivity challenges. Specifically, the event will explore the continuous manufacturing of oral solid dosage forms, high investment costs and time-consuming know-how development, and DuPont Nutrition & Biosciences’ broad portfolio of excipients.
Continuous manufacturing: Current and Future Role of Excipient SuppliersTuesday Nov. 5, 201912:30-1:00CPhI Theater (61D61)
CPhI Worldwide will take place on Nov. 5 -7, 2019 in Frankfurt, Germany.
Source: CPhI Worldwide
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.